Helix is a population genomics company that provides DNA sequencing and genetic testing services for both consumers and healthcare applications. The company offers comprehensive genetic analysis through its Exome+ sequencing technology, which sequences all protein-coding genes plus additional genomic regions. Helix partners with various organizations to provide genetic insights for health, wellness, and ancestry purposes. The company has built one of the largest genomic databases and focuses on making genetic information accessible and actionable.
Helix has received investment from 1 venture capital firm.
Population genomics company providing DNA testing and genetic insights for consumers and healthcare providers.
Helix has received investment from Illumina Ventures. These venture capital firms and investors provide both capital and strategic support.
Helix has raised $200M in total funding, with their most recent round being a Series B. The company operates in the Biotech sector.
Helix was founded in 2015 and is headquartered in San Mateo, CA.
Helix operates in the Biotech sector. Population genomics company providing DNA testing and genetic insights for consumers and healthcare providers.
